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In vivo cigarette smoke exposure 
Decreases ccl20, slPi, and BD-1 
secretion by human Primary nasal 
epithelial cells
James Jukosky1 , Benoit J. Gosselin2 , Leah Foley1 , Tenzin Dechen3 , Steven Fiering3 and 
Mardi A. Crane-Godreau3*
1 Department of Natural Science, Colby-Sawyer College, New London, NH, USA, 2 Department of Otolaryngology, Dartmouth 
Hitchcock Medical Center, Lebanon, NH, USA, 3 Department of Microbiology and Immunology, Geisel School of Medicine at 
Dartmouth, Lebanon, NH, USA
Smokers and individuals exposed to second-hand cigarette smoke have a higher risk of 
developing chronic sinus and bronchial infections. This suggests that cigarette smoke 
(CS) has adverse effects on immune defenses against pathogens. Epithelial cells are 
important in airway innate immunity and are the first line of defense against infection. 
Airway epithelial cells not only form a physical barrier but also respond to the presence 
of microbes by secreting antimicrobials, cytokines, and chemokines. These molecules 
can lyse infectious microorganisms and/or provide signals critical to the initiation of 
adaptive immune responses. We examined the effects of CS on antimicrobial secre-
tions of primary human nasal epithelial cells (PHNECs). Compared to non-CS-exposed 
individuals, PHNEC from in vivo CS-exposed individuals secreted less chemokine ligand 
(C-C motif) 20 (CCL20), Beta-defensin 1 (BD-1), and SLPI apically, less BD-1 and SLPI 
basolaterally, and more CCL20 basolaterally. Cigarette smoke extract (CSE) exposure 
in vitro decreased the apical secretion of CCL20 and beta-defensin 1 by PHNEC from 
non-CS-exposed individuals. Exposing PHNEC from non-CS exposed to CSE also 
significantly decreased the levels of many mRNA transcripts that are involved in immune 
signaling. Our results show that in vivo or in vitro exposure to CS alters the secretion of 
key antimicrobial peptides from PHNEC, but that in vivo CS exposure is a much more 
important modifier of antimicrobial peptide secretion. Based on the gene expression 
data, it appears that CSE disrupts multiple immune signaling pathways in PHNEC. Our 
results provide mechanistic insight into how CS exposure alters the innate immune 
response and increases an individual’s susceptibility to pathogen infection.
Keywords: cigarette smoke exposure, primary nasal epithelium, antimicrobial peptides, ccl20, beta defensing-1, 
slPi, innate immune response, nasal epithelial cell culture
inTrODUcTiOn
There is copious evidence that exposure to primary cigarette smoke (CL) and/or second-
hand cigarette smoke (SHCS) is associated with increased frequency of infections or other 
symptoms of perturbations of the immune system. Exposure to primary CL or SHCS is a 
risk factor for recurrent otitis media, upper respiratory tract infection (1, 2), meningococcal 
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infection (3), bacteria pneumonia, oral candidiasis (4, 5), 
type 2 herpes simplex virus (6), pneumococcal disease, influ-
enza (7), asthma (8–11), and rhinosinusitis (12). One recent 
review of the epidemiology of smoke exposure and infection 
concludes that “Cigarette smoking is a substantial risk factor 
for important bacterial and viral infections” (7).
Cigarette smoke exposure alters the physiology of the upper 
airway. Evaluation of adenoid tissue removed from children living 
in SHCS-contaminated environments demonstrates significant 
histopathological and ultrastructural differences in these upper 
airway immune tissues when compared to children not exposed 
to SHCS (1). In studies of the effect of CS-extract on adherence 
of respiratory pathogens to buccal epithelial cells, CS-extract 
increased bacterial binding to the cells (13). Upper airways of 
CS-exposed individuals harbor more potential pathogens than 
those of non-smokers (14). These findings are consistent with 
studies in mice. For example, when mice exposed to CS were 
compared to mice with sham exposure, CS-exposed mice were 
less able to clear Pseudomonas aeruginosa. Besides the delayed rate 
of clearance, mice exposed to CS experienced increased inflam-
mation (15). In studies looking at changes in immune responses 
to bacterial challenge in mice exposed to nicotine, exposed mice 
exhibited significantly higher titers of influenza virus following 
infection (16). Subsequent studies of human monocytes exposed 
to bacterial toxins and then to cigarette smoke extract (CSE) 
demonstrated extremely aberrant immune responses relative to 
cells exposed to bacterial toxins but not exposed to CSE (17).
A major function of the mucosal epithelium is innate immune 
protection (18, 19). Beyond providing a physical barrier between 
the external environment and the body itself in the digestive, 
reproductive, and respiratory organs, the epithelium produces 
a complex multifaceted mucus layer that lines mucosal surfaces 
(20). To maintain balance with the body’s normal flora and to 
suppress infections, epithelial cells monitor their environment 
and respond to microbial challenges by altering secretions into 
the luminal environment. Partners with the epithelial cells in the 
delicate balancing act with microbial flora are leukocytes that 
can also recognize a microbial threat and respond by altering 
secretions. In response to threatening microbes recognized by 
epithelial cells and/or by leukocytes, airway mucosal epithelium 
produce antimicrobial proteins, including defensins, lysozyme 
(LYZ), lactoferrin (LF), secretory leukocyte protease inhibitor 
(SLPI), and chemokine ligand (C–C motif) 20 (CCL20) (19, 
21–23). LYZ is a cationic bacteriolytic protein produced by 
mucosal epithelial cells, another cationic protein is LF that 
impedes bacterial growth and replication by sequestering iron. 
LYZ and LF are both released by the nasal epithelium (24). SLPI, 
a low molecular weight protease inhibitor with an antimicrobial 
domain is also found in nasal secretions (25, 26). Small cationic 
peptides, including defensins and defensin-like CCL20, exert 
their effect through electrostatic interactions with bacterial mem-
branes that puncture the microbial cell. Recently, CCL20 has also 
been found to exhibit antiviral activity as well (27). In addition to 
antimicrobial activity, many of these peptides, including human 
beta-defensin 2 (BD2) and CCL20, also serve as chemokines to 
recruit specialized immune cells carrying the CCR6 receptor to 
the site of an infection (24, 28, 29).
The airway mucosa produces antimicrobials both constitutively 
and in response to recognition of microbes. To recognize potential 
pathogens, the innate immune system relies on pathogen associ-
ated molecular patterns (PAMP) that are unique to microbes. One 
group of receptors that recognize PAMP is the toll-like receptors 
(TLR) that are expressed on epithelial cells as well as most special-
ized immune cells. PAMP ligands are repeated in a wide variety 
of pathogenic microbes, including bacteria, fungi, and viruses. 
TLR ligands include lipoteichoic acid (LTA), derived from Gram-
positive bacteria (30). Common to TLR in mammals is the ability 
to induce effects through activation of the transcription factor 
NFκB, and through mitogen-activated protein kinases (MAPKs) 
independent of NFκB (31). TLR activation results in an induc-
tion of many molecules, including antimicrobials and cytokines 
necessary for innate and adaptive immune protection (16, 32, 33).
As noted above, it is clear that CS perturbs the response to 
pathogens. Although various experiments have associated CS 
exposure with specific immune system perturbations, the mecha-
nisms involved are not yet fully understood. An understanding of 
those mechanisms will provide new prognostic, diagnostic, and 
therapeutic approaches to smoke-related morbidity and mortal-
ity. The experiments reported here tested the hypothesis that CS 
exposure in vivo or in vitro suppresses the release of antimicrobial 
peptides from primary human epithelial cells.
Our group has shown that in vitro CSE exposure reduces pro-
duction of the antimicrobial peptide CCL20 in Beas-2b, immor-
talized human bronchial epithelial cells (34). However, Beas-2b, 
although not transformed, is a line that has been maintained 
in culture for long periods and is a genetic representation of a 
single individual. In order to examine the effect of CS exposure 
on antimicrobial peptide secretion in true primary cells, we estab-
lished short-term cultures of primary human nasal epithelial 
cells (PHNECs) from smoke-naïve individuals and smokers, and 
assayed antimicrobial peptide secretion.
MaTerials anD MeThODs
influence of In vivo cigarette smoke 
exposure on the antimicrobial secretions 
of Phnec
Beta-defensin 1 (BD1), CCL20, and SLPI secretion were assayed in 
cells obtained from CS-exposed individuals and individuals with 
no CS exposure. PHNECs were obtained from 13 individuals with 
no CS exposure and 7 individuals with significant primary CS or 
SHCS exposure. PHNECs were obtained and cultured as described 
in section below. As noted by other groups studying PHNEC, it was 
much more difficult to culture PHNEC from CS-exposed individu-
als compared to non-CS-exposed individuals (Carson, personal 
communication). Four experimental treatments were performed 
using both in vivo smoke-exposed PHNEC and cells from smoke-
naïve individuals. These treatments were constitutive secretion 
where nothing was applied, CSE exposed, LTA stimulation (LTA 
stimulated) to simulate a bacterial infection, and CSE exposed with 
LTA stimulation. CSE-exposed primary human nasal cell cultures 
were treated apically with 300 μL 1× CSE in air–liquid interface 
(ALI) for 3 h, other treatments received ALI only. This CSE exposure 
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did not increase cell death significantly 24 h later (data not shown). 
CSE was then removed by suction and cells were rinsed twice with 
PBS. Then LTA-exposed cell cultures were stimulated apically with 
LTA from Bacillus subtilis (10 μg/mL) in ALI media by applying 
300 uL in the apical compartment. PHNECs were incubated for 
20 h, and after this period apical and basolateral supernatants were 
harvested. Cell supernatants were centrifuged at 17,000 ×  g for 
10 min and the supernatants were removed and stored at −80°C. 
BD1, secretory leukocyte protease inhibitor (SLPI), and CCL20 
were assayed by ELISA in apical and basolateral secretions either 
using commercially prepared assay kits or ELISAs developed from 
ELISA development kits (R&D systems, Mckinley, MN, USA, or 
Leinco Technologies, St. Louis, MO, USA).
A two-way analysis of variance (ANOVA) was used to examine 
the effect of treatment (constitutive, CSE exposed, LTA stimu-
lated, and CSE exposed with LTA stimulation) or smoking status 
(in vivo smoke-exposed versus cells from smoke-naïve individu-
als) and any interactions between treatment and smoking status 
on PHNEC secretions. Data were natural log (ln) transformed for 
analysis to meet the underlying ANOVA assumption of a normal 
distribution. Post hoc analyses were carried out with Tukey’s HSD 
tests. All statistics and data transformations were performed 
using JMP 11.
Phnec culture
Primary human nasal epithelial cells were obtained from smoke-
exposed and non-smoke-exposed healthy human volunteers and 
differentiated in vitro in transwells as described by Carson et al. 
(35). The criteria for recruiting subjects were similar to those 
described previously (35, 36). We determined smoke exposure 
status via questionnaire and confirmed it through measurement 
of urine cotinine.
Primary human nasal epithelial cells were collected from 
healthy smoking and non-smoking adult volunteers by gently 
scraping the inferior surface of the turbinate five to eight times 
with a Rhinopro™ curette (Arlington Scientific, Arlington, TX, 
USA). The curette was inserted through a nasoscope, which 
was used to visualize the inferior turbinate. This protocol was 
approved by the Institutional Review Board of the Geisel School 
of Medicine at Dartmouth.
Primary human nasal epithelial cells from nasal scrapes were 
seeded on human collagen-coated wells of a 12-well plate and 
grown to 70% confluence in ALI media (Lonza Biologics). At 
70% confluence, PHNECs were trypsinized and seeded into 
flasks and grown in media that was one part ALI and two parts 
bronchial epithelial growth medium (BEGM) (Lonza Biologics). 
PHNEC in flask were grown to 70% confluency and subsequently 
trypsinized and seeded into collagen-coated filter supports with a 
0.4-μM pore size (Trans-CLR; Costar, Cambridge, MA, USA) and 
grown in ALI media. We promoted mucociliary differentiation 
of PHNEC after cells grew to confluency by supplementing the 
media with all-trans retinoic acid and the media was removed 
from the apical compartment to create ALI culture conditions. 
We observed mucociliary differentiation 14–21  days after ALI 
differentiation and the cultures of PHNEC were utilized experi-
mentally at this stage.
smoke extract generation
Cigarette smoke extract was generated by using vacuum suction 
to draw the smoke from a single research reference grade cigarette 
(Kentucky Cigarette Research and Development Center at the 
University of Kentucky, Lexington, KY, USA) through 100 mLs 
of ALI media in a controlled manner.
Time-course experiments
Primary human nasal epithelial cells were obtained from four 
non-smoke-exposed individuals, expanded, and differentiated 
as described previously. Constitutive, CSE, LTA, and LTA + CSE 
treatments were established as described previously. Three wells of 
cells per individual were used in each treatment. At time points of 
1 and 6 h after LTA stimulation, we harvested cells apical and baso-
lateral supernatants and RNA (for time-course gene expression). 
Apical and basolateral BD1 and CCL20 secretion were measured 
using ELISA. A repeated measures MANOVA was used to test for 
differences in CCL20 and BD-1 secretion between the four treat-
ments previously described and time points (1 and 6 h post-LTA 
stimulation). Bonferroni-corrected t-tests were used post hoc to 
identify significant differences between specific treatments.
Expression of 511 immunology-related genes was quantified 
using Nanostring technology. We analyzed expression at the 
1 and 6 h time point post-LTA stimulation and compared LTA 
and CSE + LTA treatments. RNA was extracted from individual 
transwells (n = 12) using a Qiagen Allprep kit. The total counts of 
mRNAs were assayed using nCounter GX Human Immunology 
gene expression code set that uses molecular barcodes attached 
to target-specific probes. Barcoded probes hybridize directly 
to their RNA targets in solution, and the probes are counted 
directly using microscopic imaging. Following the manufacturer’s 
protocol, 100 ng mRNA was hybridized with the nCounter GX 
Human Immunology code set and loaded into the nCounter 
prep station followed by imaging and quantification using the 
nCounter Digital Analyzer. Quality control and data normaliza-
tion were performed using the nSolver analysis software. Data 
were normalized to global means for internal positive controls, 
and subsequently normalized to the geometric means of a suite 
of housekeeping genes. Two reference genes (GUSB and HPRT1) 
were eliminated from the normalization panel because their 
average raw count data varied more than 1 SD between LTA and 
CSE + LTA treatments. The panel of genes used for normalization 
included genes with both low and high expression levels.
Specific samples from each individual were paired when experi-
ments were designed and assigned to separate treatments. Gene 
expression in the LTA-stimulated treatment and the LTA + CSE 
treatments were compared by matched pair t-test separately at 
each time point. No corrections were made for multiple compari-
sons as each barcode is considered an independent assay.
resUlTs
Phnecs from cs-exposed individuals 
Were Difficult to culture
To examine the difference in antimicrobial secretions between 
PHNEC from smokers and non-smokers and their response 
FigUre 1 | Phnec sampled from cigarette smoke-exposed 
individuals fail to grow into confluent ali cultures more often than 
Phnec from non-smoke-exposed individuals. A successful culture was 
defined as one that grew to confluency in a transwell and differentiated into a 
ciliated, mucus-producing air–liquid interface culture.
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to CSE exposure, cultures were established from each group. 
While PHNEC from non-smokers grew readily, PHNEC from 
smokers generally grew poorly and only a fraction of the donors 
provided cells that could be grown to the required level for 
the assays. Here, 86.6% of nasal scrapes from healthy donors 
(n = 15) were expanded in culture and differentiated into cili-
ated ALI cultures as described in our methods, while 33.3% of 
nasal scrapes from CS and SHS exposed individuals (n = 12) 
were able to grow and differentiate in the same manner. There 
was a significant difference between successful non-CS-exposed 
and CS-exposed PHNEC cultures using a z-test to compare two 
population proportions (z = −2.83, p = 0.002, Figure 1). These 
results reflect outcomes from a subset of nasal samples that were 
gathered after noticing this trend. This is similar to what has 
been reported by other researchers harvesting PHNEC from 
smoke-exposed individuals (Carson, personal communication).
In vivo smoke exposures alters 
antimicrobial Peptide secretions by 
Phnec
Chemokine Ligand (C–C Motif) 20
Primary human nasal epithelial cell from in  vivo CS-exposed 
individuals secreted significantly less CCL20 apically and sig-
nificantly more CCL20 basolaterally than PHNEC from non-CS-
exposed individuals. Figure 2A illustrates this finding by pooling 
all treatment groups and compares PHNEC CCL20 secretion 
from non-CS and in vivo smoke-exposed individuals. Our meas-
urements of CCL20 in the apical compartment showed that there 
was no significant effect of treatment (constitutive, CSE exposed, 
LTA stimulated, and CSE exposed with LTA stimulation) and 
no interaction between treatment and smoking status. However, 
there was a significant effect of smoking status on CCL20 secretion 
and this was highly significant in both the apical (F1,235 = 24.07, 
p < 0.0001) and basolateral (F1,171 = 12.2, p < 0.001) compart-
ments. Regardless of the treatment group, in vivo smoke-exposed 
PHNEC secreted less CCL20 apically and more CCL20 basolater-
ally than non-smoke-exposed individuals (Figure 2A). There was 
a significant effect of treatment in the basolateral compartment 
(F3,171 = 3.19, p = 0.025). Post hoc analysis showed significantly 
increased CCL20 secretion in in  vivo smoke-exposed PHNEC 
in the basolateral constitutive (p =  0.017) and basolateral CSE 
(p = 0.01) treatments (Figure 2B).
SLPI
Primary human nasal epithelial cell from in vivo CS-exposed indi-
viduals secreted significantly less SLPI apically and basolaterally 
than PHNEC from non-CS-exposed individuals. Figure 3 illustrates 
this finding by pooling all treatment groups and compares PHNEC 
SLPI secretion from non-CS and in vivo smoke-exposed individu-
als. For SLPI from cultured PHNEC, there was a highly significant 
effect of smoking status on SLPI secretion but no significant effect 
of treatment and no interaction between treatment and smoking 
status. PHNEC from non-smoke-exposed individuals had much 
higher SLPI secretions in both the apical (F1,139 = 15.2, p < 0.001) 
and basolateral (F1,154 = 25.9, p < 0.001) compartments (Figure 3). 
Regardless of the treatment group, PHNEC from smoke-exposed 
individuals secreted less SLPI apically and basolaterally than that 
from non-smoke-exposed individuals.
Beta-Defensin 1
Primary human nasal epithelial cell from in  vivo CS-exposed 
individuals secreted significantly less BD-1 apically and 
basolaterally than PHNEC from non-CS-exposed individuals. 
Figure 4 illustrates this finding by pooling all treatment groups 
and compares PHNEC BD-1 secretion from non-CS and 
in vivo smoke-exposed individuals. However, identical to SLPI, 
analysis of apical and basolateral BD-1 secretion also showed no 
significant effect of treatment and no interaction between treat-
ment and in vivo smoking status. PHNEC cultured from in vivo 
smoke-exposed individuals secreted significantly less BD-1 into 
the apical (F1,155 = 8.92, p = 0.003) and basolateral compartments 
(F1,167 = 23.1, p < 0.001) (Figure 4).
Time-course experiments
CSE Decreased Apical CCL20 Secretion in 
Unstimulated PHNEC at Hour 1 and LTA-Stimulated 
Cells at Hour 6 and Also Decreased Basolateral 
Secretion
Cigarette smoke extract exposure significantly decreased consti-
tutive apical CCL20 secretion at hour 1 (Figure 5A), but this dif-
ference was not significant at hour 6 (Figure 5B). CSE exposure 
significantly decreased LTA-stimulated apical CCL20 secretion 
**
**
p < 0.001 
p = 0.006 
* *
p < 0.017 
p < 0.01 
A B
FigUre 2 | ccl20 secretion is altered in Phnec from in vivo smoke-exposed individuals. Compared to non-smoke-exposed individuals, smoke-exposed 
individuals had significantly lower apical CCL20 secretion and significantly higher basolateral CCL20 secretion (a). Figure 2A shows secretion data pooled (from all 
treatments) from every PHNEC secretion sample. CCL20 secretion into the basolateral compartment is significantly higher in PHNEC from in vivo smoke-exposed 
individuals in the control (constitutive) and the CSE-exposed treatments (B).
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at hour 6 (Figure 5D), but this difference was not significant 1 
hour post-LTA stimulation (Figure  5C). Basolateral secretion 
of CCL20 was significantly reduced by CSE exposure at the 6 
hour time point in LTA-induced samples (Figure 6D), but not at 
1-h post-LTA stimulation (Figure 6C). Constitutive basolateral 
secretion of CCL20 was not significantly altered by CSE at the 1-h 
and 6-h time points (Figures 6A,B).
Apical CCL20 secretion was measured in each treatment at 
1 and 6 h time points; we observed a significant effect of time 
point (between subjects, F1,16 = 28.4, p < 0.001), treatment (within 
subjects, F3,14 = 16.27, p < 0.001), and interaction between time 
points (within subjects, F3,14 = 11.15, p < 0.001), and treatment for 
apical CCL20 secretion. Basolateral secretion of CCL20 showed 
no significant effect of time point but there was a significant 
effect of treatment (within subjects, F3,11 = 12.77, p < 0.001) and 
significant interaction between time point and treatment (within 
subjects, F3,11 = 6.13, p = 0.011).
No Differences Were Detected in BD-1 Secretion at 
the 1- or 6-h Time Points
No significant differences in apical or basolateral secretion of 
BD-1 were detected between CSE treated and untreated samples 
at the 1- or 6-h time point. We observed a significant effect of 
treatment with apical (within subjects, F3,17 = 5.043, p = 0.011), 
and basolateral (within subjects, F3,17 =  7.78, p =  0.004) BD-1 
secretion. However, in post hoc analysis with Bonferroni correc-
tions, no comparisons between CSE treated and untreated samples 
were significantly different at either time point (data not shown).
CSE Exposure Alters the Expression of Immune 
Related Genes after 3 h of CSE Exposure Followed 
by 1 h of LTA Stimulation
In order to further explore gene expression changes from CS 
exposure a set of 511 immunology-related genes were assayed by 
Nanostring technology. Total amounts of 20 immunology-related 
gene transcripts were significantly altered by CSE exposure out of 
511 genes assays. This difference was measured in the first hour after 
LTA stimulation. Three genes had increased number of transcripts 
and 17 were significantly decreased. By 6 h after LTA stimulation, 
these differences were minimal and a significant increase in the 
transcripts of only one other gene was detected (Table 1).
DiscUssiOn
Our results show that in vivo exposure to CS alters the secretion of 
key antimicrobial peptides from subsequently cultured PHNEC. 
FigUre 4 | Beta-defensin 1 secretion into the apical and basolateral 
compartments is significantly lower in Phnec from in vivo smoke-
exposed individuals. Beta-defensin 1 secretion was not significantly 
different among the four treatments in our PHNEC experiments. However, 
there was a significant effect of smoke exposure status and this figure shows 
secretion data pooled (from all treatments) from every PHNEC secretion 
sample.
FigUre 3 | slPi secretion into the apical and basolateral 
compartments is significantly lower in Phnec from in vivo smoke-
exposed individuals. SLPI secretion was not significantly different among 
the four treatments in our PHNEC experiments. However, there was a 
significant effect of smoke exposure status and this figure shows secretion 
data pooled (from all treatments) from every PHNEC secretion sample.
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We observed a significant decrease in apical and basolateral SLPI, 
and BD-1 secretions as well as a reduction in apical secretions 
and an increase in basolateral secretions of CCL-20 from PHNEC 
cultured from CS-exposed individuals. As these are important 
antimicrobial peptides, it shows that CS may decrease the overall 
antimicrobial activity of nasal secretions. Previous work from 
our lab has shown that CCL20 constitutes an important fraction 
of antimicrobial activity in the secretions of airway (BEAS2B) 
cells (34). PHNEC from CS-exposed individuals were more dif-
ficult to culture than that from non-smoke-exposed individuals. 
Clearly, the cells that grow out to form PHNEC cultures have 
modifications that reflect CS exposure in vivo. These modifica-
tions could be epigenetic marks. This has implications for the 
time course of recovery of normal resistance to airway pathogens 
after smoking cessation.
The in  vitro time-course data of LTA-stimulated PHNEC 
support other research showing that in vitro CS exposure alters 
the innate immune system or suppresses its ability to respond 
to pathogens. For example, Manzel et  al. (37) showed that 
CSE suppressed the activation of NF-κB-dependent pathways, 
reduced the consequent expression of defense genes [IL-8 and 
intracellular adhesion molecule 1 (ICAM-1)], and decreased cel-
lular secretion of IL-6 and IL-8 in the response to Haemophilus 
influenzae by primary human tracheobronchial epithelial cells. 
Also, cellular secretion of IL-8 and IL-6 were suppressed (37). 
Despite the fact that these same molecules did not have reduced 
expression in our transcription studies, these results in addition 
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suction and cells were rinsed twice with PBS. Subsequently, LTA and CSE + LTA treatments were stimulated apically with LTA from B. subtillis (10 μg/mL) in ALI 
media by applying 300 uL in the apical compartment. Supernatants were harvested at 1 and 6 h post-LTA stimulation. CCL20 was quantified by ELISA.
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FigUre 5 | cse exposure significantly decreased constitutive apical ccl20 secretion at hour 1 (a) and lTa-stimulated apical ccl20 secretion at 
hour 6 (B). Apical CCL20 secretion from PHNECs from non-smoke-exposed individuals are shown at 1 h (a,B) and 6 h (c,D) post-LTA stimulation. Primary human 
nasal cell cultures were exposed apically to cigarette smoke extract in ALI media for 3 h, LTA and control treatments received ALI media only. CSE was then 
removed by suction and cells were rinsed twice with PBS. Subsequently, LTA and CSE + LTA treatments were stimulated apically with LTA from B. subtillis (10 μg/
mL) in ALI media by applying 300 uL in the apical compartment. Supernatants were harvested at 1 and 6 h post-LTA stimulation. CCL20 was quantified by ELISA.
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to ours suggest that exposure to CSE weakens the innate immune 
response of the upper airway mucosa to a bacterial invasion. 
The lack of full correlation between the studies could be due to 
different anatomical sources of primary epithelial cells, different 
stimulation conditions, or different culturing techniques.
Examining the list of genes that are significantly decreased in 
LTA-stimulated PHNEC with CSE exposure reveals that many 
are involved in immune signaling. Using the KEGG pathways, 
database shows that four of the genes occur in the neurotrophin 
signaling pathway (IRAK1, PKCD, MAPK1, and MAPKAPK2), 
TaBle 1 | changes in gene expression in comparisons of cigarette smoke extract and unexposed treatments of lTa-stimulated Phnec from healthy 
individuals.
Time point gene name Mean difference with  
cse exposure
change in expression  
with cse exposure
t ratio Degrees of freedom p-value
Hour 1 ATG16L1 −26.18 Decrease −2.83831 8 0.0219
Hour 1 CD59 −652.93 Decrease −2.87 8 0.0208
Hour 1 CDKN1A −919.37 Decrease −2.31452 8 0.0493
Hour 1 CEACAM1 10.83 Increase 3.379778 8 0.0096
Hour 1 GPI 41.24 Increase 3.13942 8 0.0138
Hour 1 IFIH1 −25.28 Decrease −2.71971 8 0.0263
Hour 1 GUSB −17.83 Decrease −4.01185 8 0.0039
Hour 1 IFNAR1 −2.96 Decrease −2.96357 8 0.0180
Hour 1 IGF2R −29.66 Decrease −3.98707 8 0.0040
Hour 1 IRAK1 −49.62 Decrease −3.57147 8 0.0073
Hour 1 JAK2 −11.71 Decrease −2.71316 8 0.0265
Hour 1 MAPK1 −51.04 Decrease −3.09134 8 0.0149
Hour 1 MAPKAPK2 −33.95 Decrease −2.48863 8 0.0376
Hour 1 MARCO −15.47 Decrease −2.62623 8 0.0304
Hour 1 NOD2 25.29 Decrease 2.38436 8 0.0442
Hour 1 NOTCH2 −95.69 Decrease −3.02181 8 0.0165
Hour 1 PRKCD −24.65 Decrease −2.39875 8 0.0433
Hour 1 SLAMF7 −9.59 Decrease −3.12773 8 0.0141
Hour 1 STAT3 −88.35 Decrease −2.35686 8 0.0462
Hour 1 IL20 15.61 Increase 3.18543 8 0.0129
Hour 6 BCL3 67.53 Increase 3.040491 7 0.0188
Nanostring quantified RNA transcripts were sampled at 1 and 6 h post-LTA stimulation.
January 2016 | Volume 6 | Article 1858
Jukosky et al. Cigarette Smoke Decreases PHNEC Antimicrobials
Frontiers in Psychiatry | www.frontiersin.org
four occur in the chemokine signaling pathway (JAK2, STAT3, 
MAPK1, and PKCD), two occur in the TLR signaling pathway 
(IRAK1 and MAPK1), and three occur in the JAK-STAT signaling 
pathway (IFNAR1, JAK2, and STAT3) (38). Macrophage Receptor 
(MARCO) is a class A scavenger receptor, probably involved 
in binding Gram-positive and Gram-negative bacteria (39, 40). 
SLAMF7 was also detected as a significantly down-regulated gene 
and SLAM receptors are involved in the fine-tuning of immune cell 
activation (41). NOD2 expression was increased and this gene is an 
intracellular receptor involved in the recognition of bacterial pep-
tidoglycans and is involved in activation of NF-Kappa B, cytokine 
production, and apoptosis (42). Based on the gene expression data, 
CSE disrupts multiple chemokine, neurotrophin, and immune 
signaling pathways in PHNEC.
Our data suggest that individuals vary greatly in the amounts of 
antimicrobial peptides secreted by their PHNECs under baseline 
conditions. Constitutive and LTA-induced antimicrobial secre-
tions vary greatly among both non-smoke-exposed individuals 
and in vivo CS smoke-exposed individuals. For example, PHNEC 
from non-smoke-exposed individuals varies approximately 
60-fold from 19 to 1223 pg/ml in their secretion of CCL20 under 
control conditions and approximately 250-fold from 32 to 8000 pg/
ml in LTA-stimulated conditions (data not shown).
We had increased difficulty in culturing PHNEC from 
CS-exposed individuals, suggesting that there are other pheno-
typic differences as well, perhaps at the level of the stem cells that 
grow out to form the PHNEC cultures. We could obtain nasal 
epithelial cells from these individuals, but they would stop divid-
ing and would not proliferate enough to utilize experimentally. 
This along with our data, showing decreased secretion of antimi-
crobials from PHNEC from smoke-exposed individuals, suggests 
some transmissible epigenetic changes in CS-exposed epithelial 
stem cells from which the PHNEC are derived; these observations 
warrant further study.
The study was performed with PHNEC samples that had been 
cultured to a solid monolayer and then differentiated into mucocili-
ary epithelial cells that, like in vivo airway epithelial cells, had distinct 
differences between the apical and basolateral surfaces. Variability 
in response to secretion of the assayed proteins/peptides between 
basolateral and apical surfaces was revealed in some conditions in 
which the same cultures responded differentially between apical 
and basolateral secretion (for example, see Figure 2). This suggests 
that posttranslational regulation is affected by CS exposure. Since 
basolateral or apical secretion has different implications for fighting 
infections, it is likely that the different secretion impacts also play a 
role in sensitivity of smoke-exposed individuals to airway infections.
Antimicrobial peptides and proteins are important in protect-
ing humans from respiratory pathogens that smoke-exposed 
people are less able to control. Our results reveal clear suppressive 
effects of both in vitro and in vivo CS exposure on some of these 
defensive peptides and changes in the expression of genes involved 
in chemokine and neurotrophin signaling pathways. It is not clear 
why there are disparate effects on different specific proteins and 
peptides and an understanding of those issues requires further 
study. This report contributes to the mechanistic understanding of 
how CS exposure alters the innate immune response and increases 
an individual’s susceptibility to pathogen infection.
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